We are pleased to announce the winners of this year’s research grants, funded by the generosity of the Neuroendocrine Cancer UK community, to whom we are extremely grateful.
This funding has been carefully designed to support both shorter-term, practice-based improvements and longer-term innovation to enhance outcomes for people living with neuroendocrine cancer. This article marks the final announcement in our series and provides a summary of all awarded projects.
This year, funding is split across two grant types:
- Practice-Changing Grants (up to £5,000), supporting practical projects that can deliver real-world impact within 18 months
- Pump Priming Grants (up to £30,000), funding pilot projects aimed at generating evidence for longer-term improvements in care and outcomes
Pump Priming Grants
1. Dr Tu Vinh Luong
Royal Free Hospital NHS Trust — £30,000
Project: AI-based prediction of SSTR2 expression from H&E whole-slide images in small intestinal neuroendocrine tumours (SI-NETs), with exploratory Ki-67 grade-band estimation
Small bowel neuroendocrine tumours require a key test—SSTR2 expression—to guide diagnosis and treatment. This currently depends on a specialist scan that is not available in all hospitals, leading to delays in decision-making.
This project aims to develop an artificial intelligence (AI) tool that can analyse routine biopsy slides to estimate SSTR2 expression before scanning takes place, helping patients start appropriate treatment sooner. It will also assess how accurate, safe and practical this approach is within NHS care.
Importantly, this work could reduce uncertainty for patients at diagnosis. Many individuals currently receive detailed information about multiple treatment options, some of which may later prove unsuitable. This can increase anxiety and require additional clinical visits during an already stressful time.
2. Dr Felicity Williams
Queen Elizabeth Hospital, Birmingham — £26,500
Project: Feasibility of high-intensity prehabilitation and nutritional support before cardiothoracic surgery for carcinoid heart disease
Carcinoid heart disease is a serious complication of neuroendocrine tumours caused by damage to heart valves. It can lead to debilitating symptoms, limit access to cancer treatments, and reduce life expectancy.
Currently, around half of patients are unable to undergo potentially lifesaving surgery due to poor physical fitness linked to severe heart failure and loss of weight and muscle mass. This project will pilot a high-intensity exercise and nutritional support programme to prepare patients for surgery, with the aim of improving recovery and reducing mortality.
3. Prof. Martyn Caplin
Royal Free Hospital & University College London Hospital — £30,000
Project: A cross-organ single-cell spatial atlas of neuroendocrine carcinoma using CosMx multiplexing
Neuroendocrine carcinoma (NEC) is a rare, fast-growing cancer with limited treatment options. This research is based on the idea that NECs from different parts of the body may share common genetic abnormalities.
Using advanced technology, the study will analyse gene activity in individual cancer cells from tumour samples. By identifying shared patterns, the research aims to uncover new vulnerabilities that could be targeted by existing or future treatments, ultimately improving patient outcomes.
Practice-Changing Grants
4. Mohamed Mortagy
Hampshire Hospitals Foundation Trust — £5,000
Project: Should primary small intestinal neuroendocrine tumours and carcinoid heart disease surgery be performed in large or small centres?
Small intestinal neuroendocrine tumours (SI-NETs) are rare and often diagnosed late, with around one in four patients requiring emergency surgery. Some patients also develop carcinoid heart disease, where surgery can be life-changing.
Currently, there is no clear UK-wide guidance on where these surgeries should take place. This project will analyse national cancer registry and hospital data (2012–2021) to compare outcomes across different hospital settings.
The findings will help determine which factors influence survival and complications, supporting better referral pathways and enabling patients and clinicians to make more informed decisions.
5. Elizabeth Bradley
Queen Elizabeth Hospital, Birmingham — £3,700
Project: Body composition assessment of patients undergoing cardiac surgery for carcinoid heart disease
This project explores how nutrition and muscle strength affect recovery after heart surgery for people with carcinoid heart disease. By analysing existing patient data, researchers aim to understand whether undernutrition or low muscle mass leads to more complications or slower recovery.
The findings could help identify patients who would benefit from additional nutritional or physical support before and after surgery, improving recovery, reducing complications, and enhancing quality of life.
Together, these projects represent a powerful combination of innovation and practical change, all aimed at improving outcomes and quality of life for people affected by neuroendocrine cancer.